Rekmal Artesunate Injection 120mg

Fast-Acting Antimalarial Treatment for Severe Malaria

Rekmal Artesunate Injection 120mg is a powerful antimalarial medication used for the treatment of severe malaria caused by Plasmodium falciparum, the deadliest strain of the malaria parasite. Artesunate, the active ingredient, is a water-soluble derivative of artemisinin, known for its rapid action in reducing the parasite load in the bloodstream. This injectable form is particularly effective for treating severe or complicated cases of malaria when oral medications are not suitable.

Active Ingredient

• Artesunate (120mg): A fast-acting antimalarial agent from the artemisinin class that quickly eliminates malaria parasites from the bloodstream, providing rapid relief in severe cases.

Key Benefits of Rekmal Artesunate Injection 120mg

• Treats Severe Malaria: Highly effective in the management of severe malaria, especially when oral treatments are not feasible due to vomiting, coma, or other complications.
• Rapid Action: Artesunate works quickly to reduce the number of malaria parasites in the blood, providing fast relief and improving survival rates in critical cases.
• Trusted Artemisinin Derivative: Artesunate is derived from artemisinin, which is recommended by the World Health Organization (WHO) for the treatment of severe malaria.
• Suitable for High-Risk Areas: Used in areas where drug-resistant strains of malaria are common, providing reliable and effective treatment.

How to Use

• Administration: Rekmal Artesunate Injection is typically administered by a healthcare professional through an intravenous (IV) or intramuscular (IM) injection. The exact dosage and duration of treatment depend on the patient's body weight and the severity of the infection.
• Dosage: The standard dosage is based on body weight, with healthcare providers administering the appropriate dose as per treatment protocols. The first dose is given as soon as possible, followed by additional doses at 12 hours and 24 hours, then daily thereafter.
• Follow-Up Treatment: After initial stabilization with injectable artesunate, patients are usually transitioned to oral antimalarial medications to complete the treatment and prevent recurrence.

Important Information

• For Severe Malaria Only: This medication is intended to treat severe malaria and should only be administered by trained healthcare professionals.
• Precautions: Patients with liver or kidney conditions should inform their healthcare provider prior to administration. Artesunate may cause mild side effects, including dizziness, nausea, or transient fever.
• Side Effects: Possible side effects include low blood cell count, allergic reactions, or changes in liver function tests. Severe side effects are rare but require immediate medical attention.
• Storage: Store in a cool, dry place away from direct sunlight. Ensure the injection is kept out of reach of children.